Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: A subgroup analysis of the PRESENT Korea NovoMix® study

Diabetes, Obesity and Metabolism

Volumn 11, Issue 1, 2009, Pages 20-26

  Jang, Hack C ^a   Lee, S R ^b   Vaz, J A ^c  

^a Seoul National University Bundang Hospital   (South Korea)

^b NOVO NORDISK A S   (Denmark)

^c Novo Nordisk Pharma Singapore Pte Ltd   (Singapore)

Author keywords

Elderly diabetes; Hypoglycemia; Insulin therapy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIET RESTRICTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; KOREA; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PRESCRIPTION; PROSPECTIVE STUDY; SIDE EFFECT; WEIGHT GAIN;

EID: 58149203398     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00891.x     Document Type: Article

References (25)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. Niskanen L. Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword? Drugs Aging 1996; 8: 183-192.
4. Belmin J, Valensi P. Novel drug delivery systems for insulin: Clinical potential for use in the elderly. Drugs Aging 2003; 20: 303-312.
5. Brown AF, Mangione CM, Saliba D, Sarkisian CA. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51: S265-S280.
6. Asian-Pacific Type 2 Diabetes Policy Group. Type 2 Diabetes Practical Targets and Treatments, 4th edn. Melbourne: International Diabetes Institute (IDI), 2005; 24-28.
7. Warren ML, Conway MJ, Klaff LJ, Rosenstock J, Allen E. Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. Diabetes Res Clin Pract 2004; 66: 23-29.
8. Meneilly GS. A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes. Diabetes Obes Metab 2007; 9: 754-755.
9. Janka HU, Plewe G, Busch K. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus. J Am Geriatr Soc 2007; 55: 182-188.
10. Herz M, Sun B, Milicevic Z et al. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus. Clin Ther 2002; 24: 73-86.
11. Malone JK, Arora VK, Bue-Valleskey JM. Use of insulin lispro (Humalog®) mixtures in the elderly provides comparable safety to that of human insulin mixtures. Diabetes Res Clin Pract 2000; 50: 219.
12. Woo EK, Han C, Jo SA et al. Morbidity and related factors among elderly people in South Korea: Results from the Ansan Geriatric (AGE) cohort study. BMC Public Health 2007; 7: 10.
13. Scheen AJ. Non-insulin-dependent diabetes mellitus in the elderly. Baillieres Clin Endocrinol Metab 1997; 11: 389-406.
14. Noh JH, Kim SK, Cho YJ et al. Current status of diabetes management in elderly Koreans with diabetes. Diabetes Res Clin Pract 2007; 77: S71-S75.
15. Garber AJ, Wahlen J, Wahl T et al. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006; 8: 58-66.
16. Perriello G, Pampanelli S, Porcellati F et al. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: A randomized, stratified, double-blind and cross-over trial. Diabet Med 2005; 22: 606-611.
17. Davidson J, Liebl A, Christiansen JS et al. Biphasic insulin aspart is associated with a reduced risk of hypoglycaemia compared with biphasic human insulin. Diabetologia 2007; 50(Suppl. 1): A986.
18. Boehm BO, Vaz JA, Brondsted L, Home PD. Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes. Eur J Intern Med 2004; 15: 496-502.
19. Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2004; 65(Suppl. 1): S23-S27.
20. Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen Kruseman AC. Comparison of different insulin regimens in elderly patients with NIDDM. Diabetes Care 1996; 19: 1326-1332.
21. Reza M, Taylor CD, Towse K, Ward JD, Hendra TJ. Insulin improves well-being for selected elderly type 2 diabetic subjects. Diabetes Res Clin Pract 2002; 55: 201-207.
22. Hendra TJ, Taylor CD. A randomised trial of insulin on well-being and carer strain in elderly type 2 diabetic subjects. J Diabetes Complications 2004; 18: 148-154.
23. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/ soluble aspart) versus alternative treatment strategies. Diabetes Care 2004; 27: 2495-2497.
24. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995; 28: 173-177.
25. Corsi A, Torre E, Coronel G et al. Pre-filled insulin pen in newly insulin-treated diabetic patients over 60 years old. Diabetes Nutr Metab 1997; 10: 78-81.